TickerFacts.

Interpace Biosciences, Inc. (IDXG): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2014-12-31, 2018-12-31, 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$4.51M
Year ended 2025-12-31
$4.64M
Trailing 12 months to 2026-06-30
$8.41M2010-12-31: -$5.07M2011-12-31: -$1.66M2012-12-31: -$23.20M2013-12-31: -$12.0K2014-12-31: -$15.44M2015-12-31: -$35.38M2016-12-31: -$1.96M2017-12-31: -$2.60M2018-12-31: -$8.83M2019-12-31: -$21.91M2020-12-31: -$20.57M2021-12-31: -$962.0K2022-12-31: -$1.06M2023-12-31: $4.98M2024-12-31: $8.41M2025-12-31: $4.51M$4.51M
2010-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$4.51M-46.4%2026-03-30, From 2025-01-01
2024-12-31$8.41M+68.8%2026-03-30, From 2024-01-01
2023-12-31$4.98Mn/c2025-03-31, From 2023-01-01
2022-12-31-$1.06Mn/m2024-04-01, From 2022-01-01
2021-12-31-$962.0Kn/m2023-03-27, From 2021-01-01
2020-12-31-$20.57Mn/m2022-03-31, From 2020-01-01
2019-12-31-$21.91Mn/m2021-04-01, From 2019-01-01
2018-12-31-$8.83Mn/c2021-01-19, From 2018-01-01
2017-12-31-$2.60Mn/m2019-03-21, From 2017-01-01
2016-12-31-$1.96Mn/m2018-03-23, From 2016-01-01
2015-12-31-$35.38Mn/m2017-03-31, From 2015-01-01
2014-12-31-$15.44Mn/c2016-03-30, From 2014-01-01
2013-12-31-$12.0Kn/m2015-03-05, From 2013-01-01
2012-12-31-$23.20Mn/m2014-03-06, From 2012-01-01
2011-12-31-$1.66Mn/m2013-03-15, From 2011-01-01
2010-12-31-$5.07Mn/a2012-03-09, From 2010-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Interpace Biosciences, Inc. (IDXG)2025-12-31$4.51M-46.4%
Retractable Technologies Inc (RVP)2025-12-31-$13.41Mn/m
Cytosorbents Corp (CTSO)2025-12-31-$13.52Mn/m
ClearPoint Neuro, Inc. (CLPT)2025-12-31-$23.35Mn/m
KORU Medical Systems, Inc. (KRMD)2025-12-31-$2.16Mn/m
SS Innovations International, Inc. (SSII)2025-12-31-$7.12Mn/m
SANUWAVE Health, Inc. (SNWV)2025-12-31$5.92M+27.7%
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31-$51.48Mn/m
TriSalus Life Sciences, Inc. (TLSI)2025-12-31-$26.32Mn/m

Compare IDXG, RVP, CTSO, CLPT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗